SoftBank Vision Fund 2
软银愿景基金2期
SoftBank Vision Fund 2 is a venture capital fund that led the $110 million Series D round for global e-commerce SaaS platform Dianxiaomi in August 2022, co-leading with Sequoia China . It also co-led a $318.8 million Series C in AI drug-discovery company XtalPi in 2020 alongside Morningside and PICC Capital , and co-led a $110 million Series C in metaverse infrastructure builder Xmov in 2022 with a strategic investor . The fund's activity visible in elsewhere's corpus clusters in 2020–2022, with disclosed checks concentrated in SaaS, AI-enabled drug R&D, and metaverse infrastructure.elsewhere's corpus does not cover the fund's overall size, vintage, or full portfolio.
AI-generated — may contain errors, please verify.
Coverage
Robotics, SaaS, and innovative drug sectors close new funding rounds; chips and medical devices unveil major new products | Rongbao · August
Differentiated innovation and global opportunities.
高榕创投·Global E-commerce SaaS Platform Dianxiaomi Raises $110 Million in Series D to Accelerate International Expansion
The platform has served more than 1.5 million users worldwide and processes over RMB 350 billion in annual order transaction volume.
高榕创投·5Y News | Xmov Raises $130 Million to Build Metaverse Infrastructure
Achieving scale, interactivity, and intelligence in metaverse content.
五源资本·Morningside-backed XtalPi raises over $300 million in new funding | Light Moments
5Y Capital has long been bullish on the application of computational science in the life sciences, hoping that the convergence of IT and biotechnology will soon usher human health into a new era.
五源资本·
